New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment (Q37905046)

25 August 2017

1 reference

title

New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment (English)

1 reference

25 August 2017

0 references

1 reference

Elena Lionetti

1

1 reference

PubMed ID

21787227

25 August 2017

Carlo Catassi

series ordinal

2

1 reference

25 August 2017

1 August 2011

1 reference

International Reviews of Immunology

25 August 2017

1 reference

25 August 2017

30

1 reference

25 August 2017

4

1 reference

25 August 2017

219-231

1 reference

Genetic background of celiac disease and its clinical implications

25 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

The prevalence of celiac disease in Europe: results of a centralized, international mass screening project.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Prevalence of celiac disease among blood donors in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Prevalence of celiac disease in Egyptian children disputes the east-west agriculture-dependent spread of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Coeliac disease in Libyan children: a screening study based on the rapid determination of anti-transglutaminase antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Prevalence of celiac disease in Tunisia: mass-screening study in schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Prevalence of celiac disease among school children in Punjab, North India

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Coeliac disease epidemiology is alive and kicking, especially in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Why is coeliac disease endemic in the people of the Sahara?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

The distribution of DQ genes in the Saharawi population provides only a partial explanation for the high celiac disease prevalence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

The effect of infections on susceptibility to autoimmune and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Sourdough lactobacilli and celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Celiac disease: how complicated can it get?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Specificity of tissue transglutaminase explains cereal toxicity in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Reprogramming of CTLs into natural killer-like cells in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Tissue-mediated control of immunopathology in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Gliadin as a stimulator of innate responses in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Dental enamel defects in children with coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Oral aphthous ulcers and dental enamel defects in children with coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Hematologic manifestations of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Ironing out the mechanism of anemia in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Dermatitis herpetiformis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Short stature and the probability of coeliac disease, in the absence of gastrointestinal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Commentary on "anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear growth".

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Celiac disease in children: impact on bone health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Coeliac disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Neurologic presentation of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

The neurology of coeliac disease in childhood: what is the evidence? A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Screening for coeliac disease in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Coeliac disease and oats: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

The spectrum of celiac disease: epidemiology, clinical aspects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Celiac disease: from pathogenesis to novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

New therapeutic strategies for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Wheat deficient in gliadins: promising tool for treatment of coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Unexpected role of surface transglutaminase type II in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from alpha2-gliadin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Effect of the timing of gluten introduction on the development of celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Nutritional Management of the Gluten-free Diet in Young People with Celiac Disease in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

Natural history of celiac disease autoimmunity in a USA cohort followed since 1974

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2011.602443

10.3109/08830185.2011.602443

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21787227